Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |